|
The Pharmaceutical Journal |
|
News summary |
Boots plans to buy back sharesThe Boots Company announced this week that it is to return £300m to shareholders through a share buy back programme. Steve Russell, the company's chief executive, said on 12 March: "This is just one way in which we are aiming to enhance value for shareholders. The company is highly cash generative and remains well-placed to invest in future growth opportunities." The programme, at the current share price of 617.5p, represents 5.4 per cent of the company's share capital. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal